Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized 1:1 blinded study that evaluate in acute left heart failure-cardiogenic
shock patients if ivabradine treatment can reduce pulmonary wedge pressure, without inducing
a significant or relevant reduction in cardiac output or increasing the risk of arterial
hypotension and with the benefit of allowing a faster titration of heart failure drugs.